Updated management of pulmonary embolism - 19 JANUARY, 2026

Updated management of pulmonary embolism - 19 JANUARY, 2026

To take part in this event, you must register in advance.

You are registered to this event

18:00-19:00 CET | Online

19 January, 2026

Overview

Taking place on 19 January, this instalment will see an expert panel discuss updated management of pulmonary embolism.

 

  • risk classification;
  • advanced reperfusion therapies - ongoing trials;
  • long-term FU/long-term sequela/duration of anticoagulation.

This event is completely free to attend, but registration in advance is required.

Speakers

Prof. David Jiménez Castro (Co-chair)

  • David is Professor of Medicine at the University of Alcalá, Madrid, Spain, and Chief of the Venous Thromboembolism Programme at the Ramón y Cajal Hospital in Madrid.
  • He serves as Chief of the Respiratory Department of Ramon y Cajal Hospital.
  • Dr Jiménez's interests include venous thromboembolism, and clinical care, education and research for patients with pulmonary embolism (PE).
  • He is past President of the Vascular Sections of both the Spanish Society of Respiratory Medicine (SEPAR) and the Madrid Society of Respiratory Medicine (NEUMOMADRID), and past President of the Pulmonary Embolism Group of the European Respiratory Society.

Prof. Irene Lang (Co-chair)

  • Irene is a clinical cardiologist and Professor of Vascular Biology at the Medical University of Vienna.
  • She has been nominated as one of the WMA-Caring Physicians of the World in 2005.
  • She directs an out-patient clinic for pulmonary vascular diseases and is an active interventional and structural cardiologist.
  • She also leads basic research on the biology of vascular occlusions, with a special focus on chronic thromboembolic pulmonary hypertension.
  • Prof. Lang is a Member of the Austrian and European societies of cardiology, member of senate of the Medical University of Vienna and Editor for the pulmonary vascular section at the European Heart Journal, of Pulmonary Circulation, and Atherosclerosis.

Speakers to be announced soon.